Elanco (ELAN): are the analysts right?

Elanco · Health Care · ref. ETF XLV · 57 calls · price $24.84
What the company does: Elanco Animal Health innove et commercialise des produits de santé pour animaux de compagnie et d'élevage mondialement.
📈 1-year price
$24.64+67.1% over range
Jul 8, 25low $13.68 · high $26.84Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
86% recommend buying · 7 analysts

🎯 Analyst price target on ELAN

High target · 1 analyst$32+28.8%
Median target · 7 analysts$30+20.8%
Low target · 1 analyst$24-3.4%
Current price$24.84

🗳️ The analyst consensus

Analyst breakdown · 7 (6 months)
Strong Buy0%
Buy86%
Hold14%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on ELAN

Most reliable analysts on ELAN (% profitable · 365j · ≥2 calls)
UBS 100% +100.2% 2
Stifel 88% +86.8% 8
Barclays 71% +36.0% 7
Goldman Sachs 44% -6.1% 9

📊 What $1,000 invested in Elanco would be worth

In short — $1,000 invested in Elanco 10 years ago would be worth $722 today, i.e. -4%/yr on average. Best year: 2025 (+88%), worst: 2022 (-57%). Price performance, excluding dividends.

If I'd invested $1,000 in Elanco

InvestmentWorth todayGain
1 years ago$2,054+105%
3 years ago$2,014+101%
5 years ago$802-20%
since inception (2018)$722-28%

Return by year (Elanco)

YearReturn$1,000 invested at year start
2026 (YTD)+9%$1,093 (+9%)
2025+88%$2,054 (+105%)
2024-20%$1,652 (+65%)
2023+22%$2,014 (+101%)
2022-57%$867 (-13%)
2021-7%$802 (-20%)
2020+5%$846 (-15%)
2019-9%$773 (-23%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on ELAN

TD Cowen
Jun 18, 26
▲ Buy · 🎯$32
Price at call : $23.9 — upside +34%
Today : $24.84 — upside +29%
🎯 on ELAN : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : Jun 18, 27
Citigroup
May 7, 26
▲ Buy · 🎯$31
Price at call : $23.65 — upside +31%
Today : $24.84 — upside +25%
🎯 on ELAN : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : May 7, 27
JP Morgan
May 7, 26
▲ Overweight · 🎯$30
Price at call : $23.65 — upside +27%
Today : $24.84 — upside +21%
🎯 on ELAN : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : May 7, 27
Citigroup
Apr 15, 26
▲ Buy · 🎯$30
Price at call : $23.13 — upside +30%
Today : $24.84 — upside +21%
🎯 on ELAN : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Apr 15, 27
■ Equal-Weight neutral · not a buy · 🎯$24
Price at call : $26.19 — gap to target -8%
Today : $24.84 — gap to target -3%
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Feb 25, 27
Keybanc
Feb 25, 26
▲ Overweight · 🎯$29
Price at call : $26.19 — upside +11%
Today : $24.84 — upside +17%
🎯 on ELAN : no call matured yet · 📊 on Health : 33.3% · -8.8% (42 calls)
in progress (365j)
matures : Feb 25, 27
▲ Outperform · 🎯$30
Price at call : $26.84 — upside +12%
Today : $24.84 — upside +21%
🎯 on ELAN : no call matured yet · 📊 on Health : 44.4% · -4.7% (9 calls)
in progress (365j)
matures : Feb 24, 27
JP Morgan
Feb 19, 26
▲ Overweight · 🎯$28
Price at call : $24.98 — upside +12%
Today : $24.84 — upside +13%
🎯 on ELAN : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Feb 19, 27
Piper Sandler
Jan 22, 26
▲ Overweight · 🎯$30
Price at call : $24.91 — upside +20%
Today : $24.84 — upside +21%
🎯 on ELAN : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Jan 22, 27
■ Equal-Weight neutral · not a buy · 🎯$22
Price at call : $22.3 — gap to target -1%
Today : $24.84 — gap to target -11%
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Dec 18, 26
Barclays
Dec 9, 25
▲ Overweight · 🎯$30
Price at call : $21.3 — upside +41%
Today : $24.84 — upside +21%
🎯 on ELAN : 71% (7 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Dec 9, 26
Keybanc
Nov 21, 25
▲ Overweight · 🎯$27
Price at call : $22.25 — upside +21%
Today : $24.84 — upside +9%
🎯 on ELAN : no call matured yet · 📊 on Health : 33.3% · -8.8% (42 calls)
in progress (365j)
matures : Nov 21, 26
UBS
Nov 6, 25
▲ Buy · 🎯$27
Price at call : $21.49 — upside +26%
Today : $24.84 — upside +9%
🎯 on ELAN : 100% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Nov 6, 26
UBS
Oct 21, 25
▲ Buy · 🎯$25
Price at call : $21.62 — upside +16%
Today : $24.84 — upside +1%
🎯 on ELAN : 100% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Oct 21, 26
JP Morgan
Oct 7, 25
▲ Overweight · 🎯$24
Price at call : $20.45 — upside +17%
Today : $24.84 — upside -3%
🎯 on ELAN : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Oct 7, 26
Stifel
Sep 24, 25
▲ Buy · 🎯$23
Price at call : $18.92 — upside +22%
Today : $24.84 — upside -7%
🎯 on ELAN : 88% (8 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Sep 24, 26
Piper Sandler
Aug 11, 25
■ Neutral neutral · not a buy · 🎯$18
Price at call : $17.1 — gap to target +5%
Today : $24.84 — gap to target -28%
🎯 on ELAN : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Aug 11, 26
UBS
Aug 8, 25
▲ Buy · 🎯$19
Price at call : $17.1 — upside +11%
Today : $24.84 — upside -24%
🎯 on ELAN : 100% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Aug 8, 26
UBS
Jul 23, 25
▲ Buy · 🎯$18
Price at call : $14.69 — upside +23%
Today : $24.84 — upside -28%
🎯 on ELAN : 100% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Jul 23, 26
▲ Outperform · 🎯$18
Price at call : $14.96 — upside +20%
Today : $24.84 — upside -28%
🎯 on ELAN : no call matured yet · 📊 on Health : 44.4% · -4.7% (9 calls)
in progress (365j)
matures : Jul 17, 26
Stifel
Jul 2, 25
▲ Buy · 🎯$17
Price at call : $14.64 — upside +16%
Today : $24.84 — upside -32%
🎯 on ELAN : 88% (8 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Jul 2, 26
William Blair
Jun 26, 25
▲ Outperform
Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (1 call matured) · 📊 on Health : 47.4% · +30.6% (19 calls)
+71.8%
stock +72% · XLV +19%
Stifel
May 19, 25
▲ Buy · 🎯$16
Price at call : $13.08 — upside +22%
Today : $24.84 — upside -36%
Expected +22% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 88% (8 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
+59.4%
stock +59% · XLV +9%
Stifel
May 8, 25
▲ Buy · 🎯$15
Price at call : $11.96 — upside +25%
Today : $24.84 — upside -40%
Expected +25% · Actual +82% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 88% (8 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
+81.6%
stock +82% · XLV +8%
Stifel
Apr 14, 25
▲ Buy · 🎯$13
Price at call : $8.24 — upside +58%
Today : $24.84 — upside -48%
Expected +58% · Actual +182% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 88% (8 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
+181.9%
stock +182% · XLV +7%
■ Neutral neutral · not a buy · 🎯$12
Price at call : $10.83 — gap to target +11%
Today : $24.84 — gap to target -52%
🎯 on ELAN : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Mar 6, 26
UBS
Feb 26, 25
▲ Buy · 🎯$17
Price at call : $10.92 — upside +56%
Today : $24.84 — upside -32%
Expected +56% · Actual +142% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)
+141.8%
stock +142% · XLV +9%
■ Equal-Weight neutral · not a buy · 🎯$13
Price at call : $10.92 — gap to target +19%
Today : $24.84 — gap to target -48%
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Feb 26, 26
Stifel
Feb 26, 25
▲ Buy · 🎯$15
Price at call : $11.13 — upside +35%
Today : $24.84 — upside -40%
Expected +35% · Actual +135% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 88% (8 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
+135.3%
stock +135% · XLV +6%
Barclays
Feb 26, 25
▲ Overweight · 🎯$19
Price at call : $11.13 — upside +71%
Today : $24.84 — upside -24%
Expected +71% · Actual +135% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 71% (7 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
+135.3%
stock +135% · XLV +6%
Stifel
Feb 21, 25
▲ Buy · 🎯$16
Price at call : $11.11 — upside +44%
Today : $24.84 — upside -36%
Expected +44% · Actual +123% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 88% (8 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
+122.8%
stock +123% · XLV +7%
■ Equal-Weight neutral · not a buy · 🎯$14
Price at call : $12.47 — gap to target +12%
Today : $24.84 — gap to target -44%
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Jan 29, 26
Stifel
Jan 7, 25
▲ Buy · 🎯$18
Price at call : $11.55 — upside +56%
Today : $24.84 — upside -28%
Expected +56% · Actual +101% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 88% (8 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
+101.2%
stock +101% · XLV +13%
UBS
Dec 9, 24
▲ Buy · 🎯$18
Price at call : $12.88 — upside +40%
Today : $24.84 — upside -28%
Expected +40% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 100% (2 calls matureds) · 📊 on Health : 47.1% · +16.6% (102 calls)
+58.6%
stock +59% · XLV +4%
■ Market Perform neutral · not a buy · 🎯$14
Price at call : $13.48 — gap to target +4%
Today : $24.84 — gap to target -44%
🎯 on ELAN : no call matured yet · 📊 on Health : 44.4% · -4.7% (9 calls)
in progress (365j)
matures : Dec 2, 25
Barclays
Nov 8, 24
▲ Overweight · 🎯$20
Price at call : $14.27 — upside +40%
Today : $24.84 — upside -19%
Expected +40% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 71% (7 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
+56.1%
stock +56% · XLV -1%
Barclays
Oct 28, 24
▲ Overweight · 🎯$19
Price at call : $12.51 — upside +52%
Today : $24.84 — upside -24%
Expected +52% · Actual +81% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 71% (7 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
+80.6%
stock +81% · XLV -3%
Barclays
Sep 23, 24
▲ Overweight · 🎯$22
Price at call : $13.88 — upside +59%
Today : $24.84 — upside -11%
Expected +59% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 71% (7 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
+35.1%
stock +35% · XLV -11%
Stifel
Sep 19, 24
▲ Buy · 🎯$20
Price at call : $14.07 — upside +42%
Today : $24.84 — upside -19%
Expected +42% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on ELAN : 88% (8 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
+35.3%
stock +35% · XLV -12%
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $15.07 — gap to target -0%
Today : $24.84 — gap to target -40%
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Sep 19, 25
■ Neutral neutral · not a buy · 🎯$16
Price at call : $14.1 — gap to target +13%
Today : $24.84 — gap to target -36%
🎯 on ELAN : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Jul 1, 25
Barclays
Jun 28, 24
▲ Overweight · 🎯$21
Price at call : $14.1 — upside +49%
Today : $24.84 — upside -15%
Expected +49% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on ELAN : 71% (7 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
+1.3%
stock +1% · XLV -7%
Piper Sandler
May 13, 24
■ Neutral neutral · not a buy · 🎯$19
Price at call : $17 — gap to target +12%
Today : $24.84 — gap to target -24%
🎯 on ELAN : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : May 13, 25
Barclays
May 9, 24
▲ Overweight · 🎯$23
Price at call : $17 — upside +35%
Today : $24.84 — upside -7%
Expected +35% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on ELAN : 71% (7 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-24.6%
stock -25% · XLV -5%
Piper Sandler
Mar 12, 24
■ Neutral neutral · not a buy · 🎯$18
Price at call : $15.91 — gap to target +13%
Today : $24.84 — gap to target -28%
🎯 on ELAN : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Mar 12, 25
Goldman Sachs
Feb 27, 24
▼ Sell · 🎯$14
Price at call : $15.93 — upside -12%
Today : $24.84 — upside -44%
Expected -12% · Actual -31% · Reason (≤ −15%) : ✓ Yes
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
+31.4%
stock -31% · XLV +1%
▲ Overweight · 🎯$17
Price at call : $15.93 — upside +7%
Today : $24.84 — upside -32%
Expected +7% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on ELAN : 0% (1 call matured) · 📊 on Health : 33.3% · -9.0% (159 calls)
-31.4%
stock -31% · XLV +1%
Barclays
Feb 27, 24
▲ Overweight · 🎯$19
Price at call : $15.93 — upside +19%
Today : $24.84 — upside -24%
Expected +19% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on ELAN : 71% (7 calls matureds) · 📊 on Health : 47.8% · +1.6% (186 calls)
-31.4%
stock -31% · XLV +1%
Goldman Sachs
Jan 17, 24
▼ Sell · 🎯$12.5
Price at call : $14.8 — upside -16%
Today : $24.84 — upside -50%
Expected -16% · Actual -19% · Reason (≤ −15%) : ✓ Yes
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
+18.8%
stock -19% · XLV +1%
Stifel
Jan 5, 24
▲ Buy · 🎯$20
Price at call : $15.45 — upside +29%
Today : $24.84 — upside -19%
Expected +29% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on ELAN : 88% (8 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
-22.9%
stock -23% · XLV -0%
▼ Sell · 🎯$9.5
Price at call : $12.22 — upside -22%
Today : $24.84 — upside -62%
Expected -22% · Actual +7% · Reason (≤ −15%) : ✗ No
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
-6.7%
stock +7% · XLV +11%
▼ Sell · 🎯$9.5
Price at call : $12.27 — upside -23%
Today : $24.84 — upside -62%
Expected -23% · Actual +6% · Reason (≤ −15%) : ✗ No
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
-5.9%
stock +6% · XLV +11%
Goldman Sachs
Apr 26, 23
▼ Sell · 🎯$9
Price at call : $9.25 — upside -3%
Today : $24.84 — upside -64%
Expected -3% · Actual +41% · Reason (≤ −15%) : ✗ No
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
-41.0%
stock +41% · XLV +6%
Goldman Sachs
Apr 25, 23
▼ Sell · 🎯$9
Price at call : $9.33 — upside -4%
Today : $24.84 — upside -64%
Expected -4% · Actual +43% · Reason (≤ −15%) : ✗ No
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
-42.7%
stock +43% · XLV +5%
▼ Sell · 🎯$12
Price at call : $12.26 — upside -2%
Today : $24.84 — upside -52%
Expected -2% · Actual -13% · Reason (≤ −15%) : ✗ No
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
+12.9%
stock -13% · XLV -6%
Goldman Sachs
Jul 21, 22
▼ Sell · 🎯$19
Price at call : $20.6 — upside -8%
Today : $24.84 — upside -24%
Expected -8% · Actual -42% · Reason (≤ −15%) : ✓ Yes
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
+41.6%
stock -42% · XLV +5%
Goldman Sachs
May 19, 22
▲ Buy · 🎯$32
Price at call : $23.24 — upside +38%
Today : $24.84 — upside +29%
Expected +38% · Actual -63% · Reason (≥ +15%) : ✗ No
🎯 on ELAN : 44% (9 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
-63.4%
stock -63% · XLV +2%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)